GLD vs PHAT
SPDR® Gold Shares (GLD) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
GLD does not have a complete income-statement cache yet.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
GLD currently screens at market cap $0. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the GLD and PHAT stock pages for the full models.
Not investment advice.